Revenues of USD 51m (+11% vs. ARCe, +4% vs. cons)EBITDA of USD 23m (+4% vs. ARCe, -1% vs. cons)Dividend guidance slightly increasedContinues to evaluate accretive growth opportunitiesNeutral report - we expect the share to trade in line with peers
Sign up to access
Get access to our full offering from over 100 providers
Get access to our full offering from over 100 providers
Revenues of USD 51m (+11% vs. ARCe, +4% vs. cons)EBITDA of USD 23m (+4% vs. ARCe, -1% vs. cons)Dividend guidance slightly increasedContinues to evaluate accretive growth opportunitiesNeutral report - we expect the share to trade in line with peers
